Details
Stereochemistry | ACHIRAL |
Molecular Formula | C16H13I3N2O3 |
Molecular Weight | 661.9994 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
NC1=C(I)C=C(I)C(C(=O)N(CCC(O)=O)C2=CC=CC=C2)=C1I
InChI
InChIKey=FJYJNLIEGUTPIJ-UHFFFAOYSA-N
InChI=1S/C16H13I3N2O3/c17-10-8-11(18)15(20)14(19)13(10)16(24)21(7-6-12(22)23)9-4-2-1-3-5-9/h1-5,8H,6-7,20H2,(H,22,23)
Molecular Formula | C16H13I3N2O3 |
Molecular Weight | 661.9994 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Iobenzamic acid is a contrast medium, which was used for cholecystography under the name Osbil. It is assumed that the drug is no longer marketed.
Approval Year
Sample Use Guides
In Vivo Use Guide
Sources: http://www.ncbi.nlm.nih.gov/pubmed/14236022
Unknown
Route of Administration:
Oral
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 17:20:09 GMT 2023
by
admin
on
Fri Dec 15 17:20:09 GMT 2023
|
Record UNII |
F72UWG2SWK
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
WHO-ATC |
V08AC05
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
||
|
WHO-VATC |
QV08AC05
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
3759
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
DTXSID9057711
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
DB13428
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
F72UWG2SWK
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
CHEMBL2106317
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
100000083421
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
3115-05-7
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
C170072
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
m772
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | Merck Index | ||
|
Iobenzamic acid
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
221-484-1
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
SUB08204MIG
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
1560
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY | |||
|
18377
Created by
admin on Fri Dec 15 17:20:09 GMT 2023 , Edited by admin on Fri Dec 15 17:20:09 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |